Wellington Management Group
THRX

Wellington Management Group’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Wellington Management Group’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-153,673
Closed -$1.43M – 1902
2023
Q2 		$1.43M Buy
153,673
+42,061
+38% +$414K ﹤0.01% 1540
2023
Q1 		$991K Buy
+111,612
New +$1.1M ﹤0.01% 1658
2022
Q4 		– Sell
-172,566
Closed -$1M – 2147
2022
Q3 		$1M Buy
172,566
+112,411
+187% +$794K ﹤0.01% 1652
2022
Q2 		$332K Sell
60,155
-233,432
-80% -$1.93M ﹤0.01% 1934
2022
Q1 		$3.38M Sell
293,587
-331,233
-53% -$3.54M ﹤0.01% 1487
2021
Q4 		$7.92M Buy
+624,820
New +$9.43M ﹤0.01% 1327

Other funds holding THRX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Wellington Management Group's THRX Position: Q3 2023 in Review

Wellington Management Group sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q3 2023, closing a stake of 153,673 shares — an estimated $1.43M sold.

Wellington Management Group first reported a position in THRX in Q4 2021 and held it in 6 quarters. The position peaked at $7.92M in Q4 2021. 63 funds tracked by Wall St. Rank hold THRX as of Q3 2023.

  • Wellington Management Group reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Wellington Management Group sold 153,673 Theseus Pharmaceuticals, Inc. Common Stock shares in Q3 2023, an estimated $1.43M.
  • Wellington Management Group first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Wellington Management Group's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $7.92M in Q4 2021.
  • 63 funds tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q3 2023.

Based on Wellington Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.